adipogenic medium in which individual EGM2 factors were omitted. Twenty-five days later, RNAs were prepared and analyzed for the indicated genes. PLIN1 and UCP1 levels were taken as 1 in the complete EGM2 adipogenic medium. B) hiPSC-BAP differentiation in EGM2 and defined adipogenic medium. hiPSC-BAPs were maintained in EGM2 adipogenic medium supplemented with SB431542 (1) or in adipogenic medium supplemented with SB431542, ascorbic acid (25.5 µg/ml), hydrocortisone (4 µg/ml) and EGF (10 ng/ml).
Twenty-five days later RNAs were prepared and analyzed for indicated makers. Values are means ± SEM. n=6. C) Effect of individual compound on TGFb pathway inhibition.
hiPSC-BAPs were stimulated for 1h with indicated factors. Then proteins were prepared and analyzed for activated Smad2/3 and EGR1 expression. a) ascorbic acid (25.5 µg/ml) plus hydrocortisone (4 µg/ml) plus EGF (10 ng/ml) plus SB431542 (5µM); b) EGF (10 ng/ml); c) hydrocortisone (4 µg/ml); d) ascorbic acid (25.5 µg/ml); e) SB431542 (5µM). * means p<0.05. 
Basal Medium

Human Genes Primers
TCA ACC TGA CGT GGC CCT TT GAC TCG CAC CTC CAA GGT C TBP ACGCCAGCTTCGGAGAGTTC CAAACCGCTTGGGATTATATTCG 
